Swiss stocks dropped as the market reopened after a holiday, on worries about the impact from US President Donald Trump’s punitive 39% export tariff and a push for drugmakers to lower prices.
The Swiss Market Index fell as much as 1.9% Monday, although it pared declines to 0.88% as of 10:15 a.m. in Zurich on optimism that the levies will ultimately be a tool to drive trade negotiations. The benchmark is now up about 1% for 2025.
Drugmakers Novartis AG and Roche Holding AG,which account for almost 30% of the index, dropped 0.7% and 1.4%, respectively. UBS ...